Controlling toxic and harmful gas in blasting with an inhibitor.

In engineering blasting, while efficiently breaking rocks with explosives, a large amount of toxic and harmful gases are generated, which not only pollutes the production environment but also easily leads to explosion smoke poisoning accidents. It must be highly valued by engineering technicians and management personnel. To effectively control the production of harmful gases during explosive blasting, an environmentally friendly and efficient harmful gas inhibitor has been developed, and its mechanism of action has been analyzed and revealed. Through model and on-site experiments, the appropriate addition ratio and charging structure scheme were determined, and good control effects were achieved. The research results indicate that the environment in which explosives are used has a significant impact on the composition of harmful gases produced during blasting. CO, NO, and NO2 are mainly produced in natural air environments, while NH3, CO, and NO are mainly produced in underground blasting environments. As the proportion of inhibitors added increases (2%, 4%, 6%), the decrease in the concentration of harmful gases during blasting first increases and then decreases. Compared with the control experiment, the total reduction rate of harmful gas concentration is 39.23%, 68.20%, and 59.69%, respectively, and the best control effect is achieved when 4% is added. When using the developed inhibitor adding device for the full hole addition scheme, the control effect of harmful gas concentration in blasting is the best, and the decrease in harmful gas concentration reaches 62.79%~84.73% at a distance of 30m~120m. The use of harmful gas inhibitors for blasting combined with other control measures can significantly improve the blasting operation environment, enhance the safety level of production operations, and have good promotion and application value.

Subtype-based analysis of cell-in-cell structures in non-small cell lung cancer.

Lung cancer is ranked as the leading cause of cancer-related death worldwide, and the development of novel biomarkers is helpful to improve the prognosis of non-small cell lung cancer (NSCLC). Cell-in-cell structures (CICs), a novel functional surrogate of complicated cell behaviors, have shown promise in predicting the prognosis of cancer patients. However, the CIC profiling and its prognostic value remain unclear in NSCLC. In this study, we retrospectively explored the CIC profiling in a cohort of NSCLC tissues by using the "Epithelium-Macrophage-Leukocyte" (EML) method. The distribution of CICs was examined by the Chi-square test, and univariate and multivariate analyses were performed for survival analysis. Four types of CICs were identified in lung cancer tissues, namely, tumor-in-tumor (TiT), tumor-in-macrophage (TiM), lymphocyte-in-tumor (LiT), and macrophage-in-tumor (MiT). Among them, the latter three constituted the heterotypic CICs (heCICs). Overall, CICs were more frequently present in adenocarcinoma than in squamous cell carcinoma (P = 0.009), and LiT was more common in the upper lobe of the lung compared with other lobes (P = 0.020). In univariate analysis, the presence of TiM, heCIC density, TNM stage, T stage, and N stage showed association with the overall survival (OS) of NSCLC patients. Multivariate analysis revealed that heCICs (HR = 2.6, 95% CI 1.25-5.6) and lymph node invasion (HR = 2.6, 95% CI 1.33-5.1) were independent factors associated with the OS of NSCLC. Taken together, we profiled the CIC subtypes in NSCLC for the first time and demonstrated the prognostic value of heCICs, which may serve as a type of novel functional markers along with classical pathological factors in improving prognosis prediction for patients with NSCLC.